A discreet recovery program for Los Angeles residents.

SB 855 replaced insurer discretion with a published clinical standard. Before it, a California plan could write its own definition of medical necessity and apply it to your case. Since 1 January 2021 it cannot.

The criteria are fixed by law

Decisions about service intensity, level-of-care placement, continued stay, transfer and discharge must use the most recent criteria developed by the relevant non-profit clinical specialty association — for substance use disorders, that is the ASAM Criteria. A plan may not apply different, additional or conflicting criteria of its own.

The whole condition, not the crisis

The law explicitly prohibits limiting coverage to treating the acute symptoms of a behavioural health condition rather than the underlying condition causing them. Withdrawal management alone is not treatment, and in California a plan cannot behave as though it were.

The full ladder is in scope

All medically necessary benefits are covered — office visits, intensive outpatient, residential treatment and hospital stays — at the level of care that is clinically appropriate, safe and effective.

Why this matters when a denial arrives

A denial that cites the plan’s own internal criteria rather than the ASAM Criteria is a denial on the wrong basis. Ask in writing which criteria were applied. Plans must supply them, and that request is where most successful appeals in this state begin.

Three moves, none of which require a solicitor, and all of which can be done before you speak to any facility.

Establish whether your plan is California-regulated

Member services will say. A plan regulated by the Department of Managed Health Care or the Department of Insurance is covered by SB 855; a self-funded employer plan is governed by federal law instead. This single answer decides which rulebook applies to you.

Insist the assessment names the dimensions

Because approval is measured against the ASAM Criteria, an assessment that documents the six dimensions is not bureaucracy — it is the thing your coverage rests on. A programme that will not tell you which dimension drove its recommendation cannot document it to a plan either.

Ask for the criteria in writing on any denial

Not a summary of the decision. The criteria applied. If they are not the current ASAM Criteria, the denial is contestable on its face, and California’s independent medical review process exists for exactly this.

Drug-related overdose deaths in LA County fell from 3,137 in 2023 to 2,438 in 2024 — down 22%, the largest single-year decline the county has recorded and the lowest total since 2019.

The composition changed, not only the count

Fentanyl-related deaths fell 37% and methamphetamine-related deaths 20%. The share of accidental overdose deaths involving fentanyl dropped from 64% to 52%, and for the first time in years fentanyl deaths fell below methamphetamine deaths.

Why the stimulant half matters here

That crossover is the local fact with the most practical consequence: for stimulants there is no FDA-approved medication. The treatment with the strongest evidence is contingency management, a behavioural approach that is unevenly available and that many programmes do not run at all. In a market where methamphetamine now outweighs fentanyl in the death data, whether a programme actually offers it is a real differentiator rather than a brochure line.

What a Los Angeles programme should be able to answer

Whether it runs contingency management, who delivers it, and how often. The answer is either a schedule or a shrug, and the difference tells you whether the evidence base reached the brochure.

Why the county numbers belong in your decision

Because they describe the network you step down into. Capacity that grew this fast is capacity you will be handed to when the intensive phase ends — and that handover is the part that most often decides whether the gains hold.

What the numbers do not say

They do not say the supply became safer, and they do not describe non-fatal harm. LA County scaled prevention, treatment and harm-reduction investment substantially over this period; the decline is best read as capacity working, not as risk disappearing.

Southern California has the densest concentration of private treatment marketing in the country, and the widest gap between what is advertised and what is delivered. These four signals are visible before you ever speak to anyone.

1. The page ranks facilities but names no method

“Top 10 rehabs in Los Angeles” lists are advertising. A ranking without a stated method is a placement fee with a headline.

2. The first question is your insurance, not your history

A clinician performing an assessment asks what you take, for how long, what else is prescribed and what home looks like. A broker asks for your plan and your location inside ninety seconds.

3. Amenities lead, clinicians are absent

Chef, pool, ocean view, equine. If the same page cannot tell you the clinician-to-guest ratio, who prescribes, or what happens at 2am, the amenities are the product.

4. Nobody will say who it is not for

A programme that has decided what it does can say what it does not do. In this market that sentence is rare enough to be a filter on its own.

Addiction treatment records carry federal protection beyond ordinary medical privacy under 42 CFR Part 2. That rule was written for this category of care specifically, and it restricts disclosure in ways HIPAA alone does not.

The Los Angeles version of the problem

Exposure here is rarely the claim file. It is proximity: a production schedule, an agent, a colleague who knows the same clinician, a facility whose car pulls up somewhere recognisable. That is an operational problem, and it has operational answers.

What we do

No photographs, no social presence, no discharge dates, unmarked transport, and one named contact rather than a rota. Where a counterparty genuinely must be told something, we would rather help you decide what is said in advance than discover afterwards what was assumed.

The option most people overlook

Structured outpatient. It keeps you in your own life and produces no month-shaped absence for anyone to explain — and for a great many people it is also what the assessment indicates. The private-residential default is often bought for reassurance rather than for clinical reasons.